Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Probi AB (PROB) NPV

Sell:260.00 SEK Buy:261.50 SEK Change: 9.00 SEK (3.35%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:260.00 SEK
Buy:261.50 SEK
Change: 9.00 SEK (3.35%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:260.00 SEK
Buy:261.50 SEK
Change: 9.00 SEK (3.35%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Probi AB is a Sweden-based company engaged in the probiotics research and development. The Company’s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies and firms related to the production of probiotics and self-care goods. Its brands portfolio comprises two trademarks: Probi Digestis and Probi Defendum. The Company's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others. The Company is a parent of Probi Food AB and Probi Feed AB.

Contact details

Address:
Solvegatan 41 A
LUND
223 62
Sweden
Telephone:
+46 (46) 2868920
Website:
www.probi.se

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
PROB
ISIN:
SE0001280355
Market cap:
3.13 billion SEK
Shares in issue:
11.39 million
Sector:
Biotechnology
Exchange:
Stockholm Stock Exchange
Country:
Sweden
Currency:
Swedish Krona
Indices:
n/a

Key personnel

  • Jean-Yves Parisot
    Chairman of the Board
  • Tom Ronnlund
    Chief Executive Officer
  • Henrik Lundkvist
    Chief Financial Officer
  • Niklas Brandt
    Vice President Human Resources & IT
  • Niklas Larsson
    Lead Scientific Affairs
  • Andy McShea
    Vice President Operations
  • Linda Neckmar
    Vice President EMEA and APAC
  • David Winkler
    Vice President Americas
  • Titti Niskanen
    Lead Research & Development (R&D)

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.